https://ci994inhibitor.com/com....putational-resources
This narrative review aims to summarize offered proof concerning the use of chemotherapy when you look at the setting of G1-2 NETs and G3 NETs. We performed literature study in PubMed Library for all articles published up to September 2022 about the efficacy of chemotherapy in NETs. Treatment regimens with STZ-5FU, CAPTEM, and anti-metabolite-based therapy will be the many energetic and tolerated in gastroenteropancreatic NETs (GEP-NETs) G1-G2, while platinum-based regimens (F
Like
Comment
Share
